Quantcast

Latest Drug safety Stories

2014-02-24 23:25:45

Xtalks presents an exciting live webinar on Thursday, March 13, 2014 at 10:00am EDT (14:00 GMT). Join keynote speaker Michal Borawski, International Pharmacovigilance Officer for the Asia-Pacific Region Affairs at Sanofi Pasteur for a one-hour discussion on Pharmacovigilance in APAC. Toronto, Canada (PRWEB) February 24, 2014 Increases in drug safety concerns in recent years due to some high profile drug withdrawals have led to a reevaluation of the pharmacovigilance process by...

2014-02-19 16:23:46

In the news release, CHPA Responds to Economic Impact Study on Prescription Requirement in WV, issued Feb. 19, 2014 by Consumer Healthcare Products Association over PR Newswire, we are advised by the company that the subheadline should read "West Liberty University Professor Predicts a Total Cost of $149.4 Million for the State" rather than "$247.6 Million" as originally issued inadvertently. The complete, updated release follows: CHPA Responds to Economic Impact Study on Prescription...

2014-02-19 12:29:05

West Liberty University Professor Predicts a Total Cost of $247.6 Million for the State WASHINGTON, Feb. 19, 2014 /PRNewswire-USNewswire/ -- The Consumer Healthcare Products Association (CHPA) today released the following statement regarding a new economic impact study conducted by Dr. Serkan Catma of West Liberty University. The study, which was supported by a grant from CHPA, examined the potential costs associated with a proposed prescription requirement for cold and allergy medicines...

2014-02-18 16:26:46

WASHINGTON, Feb. 18, 2014 /PRNewswire/ -- The Consumer Healthcare Products Association (CHPA) today released the following statement after the West Virginia State Senate passed Senate Bill 6--legislation that would require all citizens to obtain a doctor's prescription before buying safe and effective cold and allergy medicines containing pseudoephedrine (PSE)--medicines like Advil Cold & Sinus, Claritin-D, Mucinex D and Sudafed. The bill now heads to the House of Delegates for...

2014-02-05 23:28:52

National Law Firm Settles Flu Vaccine Injury Petition under the National Vaccine Injury Compensation Program. Many are not aware of Compensation Program and the short, strict deadlines that must be met in order to qualify. Wellesley Hills, MA (PRWEB) February 05, 2014 Gold law Firm, LLC recently obtained a large settlement for a 92-year old woman who had a severe reaction to the Influenza Vaccine resulting in Guillain-Barre' Syndrom (“GBS”) . The case, filed in the Court of...

2014-02-03 08:28:34

RYE, N.Y., Feb. 3, 2014 /PRNewswire/ -- Curemark, a drug research and development company focused on neurological disorders, announced that the company has been awarded 6 new patents for its enzyme delivery system. The new patents, issued in Europe, Australia and Central America, extend to 2030 and can be utilized for multiple enzyme products including CM-AT, Curemark's proprietary autism drug. "We are thrilled to receive these patents," stated Dr. Joan Fallon, Curemark founder and...

2014-01-24 08:23:52

DUBLIN, Jan. 24, 2014 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO; TASE) today announced that it has received final approval from the U.S. Food & Drug Administration (FDA) for its abbreviated new drug application (ANDA) for repaglinide tablets 1 mg and 2 mg, the generic equivalent to Prandin® Tablets (repaglinide tablets) and has commenced shipment of product. Perrigo previously launched the 0.5 mg strength in 2013. (Logo:...

2014-01-15 08:29:16

NEW DELHI, January 15, 2014 /PRNewswire/ -- - Cold and Cough remedies has conventionally remained the leading segment of the industry with a value share of 24.9% of the total sales as of 2012 - The vitamins and mineral supplements sales value have increased predominantly over the years from USD 873.9 million in 2006 to USD 1,091.9 million in 2012 - Slovakia has emerged as the fastest growing market for OTC drugs in the region...

2014-01-14 23:23:08

Xtalks and IRB Services present an exciting live webinar on Wednesday January 29, 2014 at 1:00pm EST on the Sunshine Act compliance requirements in the context of the present regulatory environment, enforcement, penalties for failure to comply, and potential unintended consequences, both good and bad. Toronto, Canada (PRWEB) January 14, 2014 In recent years, growing suspicion about the pharmaceutical industry and its motives and methods in product development and promotion has led to...

2014-01-06 16:27:33

CHARLESTON, W.Va., Jan. 6, 2014 /PRNewswire/ -- On Monday afternoon, Carlos Gutierrez, senior director of state government affairs for the Consumer Healthcare Products Association (CHPA) joined West Virginia Delegate Don Perdue and former Delegate Dr. Dan Foster for a panel discussion hosted by the Associated Press. The panel, which took place at the South Charleston campus of Marshall University as part of the AP's Legislative Lookahead event, focused on West Virginia's battle with...


Word of the Day
grass-comber
  • A landsman who is making his first voyage at sea; a novice who enters naval service from rural life.
According to the OED, a grass-comber is also 'a sailor's term for one who has been a farm-labourer.'